Publicaciones en las que colabora con Vivian Capilla González (11)

2023

  1. Generation of mesenchymal stromal cells from urine-derived iPSCs of pediatric brain tumor patients

    Frontiers in Immunology, Vol. 14

  2. Metabolic reprogramming by Acly inhibition using SB-204990 alters glucoregulation and modulates molecular mechanisms associated with aging

    Communications Biology, Vol. 6, Núm. 1

2022

  1. Heterogeneity of In Vitro Expanded Mesenchymal Stromal Cells and Strategies to Improve Their Therapeutic Actions

    Pharmaceutics, Vol. 14, Núm. 5

2021

  1. Preclinical safety evaluation of intranasally delivered human mesenchymal stem cells in juvenile mice

    Cancers, Vol. 13, Núm. 5, pp. 1-18

2020

  1. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)

    Frontiers in Immunology

2019

  1. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus

    Frontiers in Immunology, Vol. 10, Núm. JUN

  2. Human mesenchymal stem cells prevent neurological complications of radiotherapy

    Frontiers in Cellular Neuroscience, Vol. 13

  3. Inadequate control of thyroid hormones sensitizes to hepatocarcinogenesis and unhealthy aging

    Aging, Vol. 11, Núm. 18, pp. 7746-7779

2018

  1. PDGF Restores the Defective Phenotype of Adipose-Derived Mesenchymal Stromal Cells from Diabetic Patients

    Molecular Therapy, Vol. 26, Núm. 11, pp. 2696-2709

  2. miR-7 Modulates hESC Differentiation into Insulin-Producing Beta-like Cells and Contributes to Cell Maturation

    Molecular Therapy - Nucleic Acids, Vol. 12, pp. 463-477

2016

  1. Impact of transient down-regulation of DREAM in human embryonic stem cell pluripotency. The role of DREAM in the maintenance of hESCs.

    Stem Cell Research, Vol. 16, Núm. 3, pp. 568-578